influenza vaccine

(redirected from FluMist)
Also found in: Medical, Wikipedia.

influenza vaccine

[‚in·flü′en·zə vak′sēn]
(immunology)
A vaccine prepared from formaldehyde-attenuated mixtures of strains of influenza virus.
Mentioned in ?
References in periodicals archive ?
has retained complete marketing rights to the FluMist franchises from Wyeth.
Clarifying its LAIV (FluMist) guidelines issued last fall (MMWR 52[RR-13]:1-8, 2003), ACIP voted that the only people for whom the injectable inactivated vaccine is "preferred" are health care workers and household members in direct contact with severely immunosuppressed patients--those who require a protective environment, such as bone marrow recipients.
The live, attenuated, cold-adapted influenza vaccine, also known as CAIV-T (FluMist), was safe and effective in children aged 60 months to 17 years in the second year of its use for prevention of flu.
And in December, when the country's flu vaccination supply ran short, Albertsons offered the FluMist nasal spray.
Some insurance companies began covering FluMist at the start of the influenza season; others reevaluated their policies and decided to cover FluMist at least for this year, Susan Pisano of the American Association of Health Plans (AAHP) said in an interview.
Children at a designated test school received the live, attenuated vaccine (FluMist) prior to the 2003-2004 flu season, while children from two other schools in the community served as controls.
You might also consider the off-label use of Flumist, of which about 3 million doses are available this flu season.
Since joining MedImmune in 2006, she has managed the development of several new medicines, including Imfinzi, Fasenra, Lumoxiti, Siliq and FluMist Quadrivalent.
"Change are related to concerns regarding low effectiveness of [LAIV] (FluMist, Medlmmune) against influenza A(H1N1)pdm09 in the United States during the 2013-2014 and 2015-2016 influenza seasons," wrote the authors of the report.
FluMist Quadrivalent (LAIV4) also is being updated for the 2018-2019 season.
Hemispherx Biopharma announced the filing of a clinical study report on AMP-600, a Phase I/II trial of intranasal Ampligen in combination with FluMist influenza vaccine with the U.S.
So they spray children up and down the country for months with the FluMist in schools, which contains flu strains H3N2 and b/ yamagata (Aussie and Japanese), the Flumist is a live virus.